VCYT Competitors & Alternatives
Compare Veracyte Inc with similar stocks in the same industry
Diagnostics & Research
VCYT
Main Stock$57.08
Tradestie Score
62
Market Cap
$2.85B
P/E Ratio
55.4
Revenue Growth
0.2%
Analyst Upside
-14.0%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GH
Guardant Health, Inc. Common Stock
|
$167.98
|
$7.81B | - | 61 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$68.75
|
$6.00B | - | 59 | Compare |
|
BLLN
BLLN
|
$120.35
|
$5.55B | 223.3 | 62 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$17.93
|
$4.60B | 43.3 | 57 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$67.51
|
$3.26B | - | 59 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$69.11
|
$2.24B | - | 59 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.19
|
$2.22B | - | 64 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$99.24
|
$1.77B | - | 54 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$39.01
|
$1.54B | - | 51 | Compare |
|
NEOG
Neogen Corp
|
$9.34
|
$1.26B | - | 62 | Compare |
More VCYT Analysis
Data updated: Jul 02, 2026 | Industry: Diagnostics & Research (SIC 8071)
36 stocks in this industry